"Neisseria meningitidis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.
| Descriptor ID |
D009345
|
| MeSH Number(s) |
B03.440.400.425.550.550.641 B03.660.075.525.520.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neisseria meningitidis".
Below are MeSH descriptors whose meaning is more specific than "Neisseria meningitidis".
This graph shows the total number of publications written about "Neisseria meningitidis" by people in this website by year, and whether "Neisseria meningitidis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2021 | 2 | 3 | 5 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neisseria meningitidis" by people in Profiles.
-
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health. 2023 09; 5(9):e582-e593.
-
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5?years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children. Vaccine. 2023 01 27; 41(5):1153-1160.
-
Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. Int J Infect Dis. 2022 Sep; 122:1056-1066.
-
Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018. Clin Infect Dis. 2022 May 30; 74(10):1729-1735.
-
The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J Infect Dis. 2021 09 01; 224(12 Suppl 2):S161-S173.
-
The Role of Molecular Testing in Pediatric Meningitis Surveillance in Southern and East African Countries, 2008-2017. J Infect Dis. 2021 09 01; 224(12 Suppl 2):S194-S203.
-
Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities. Clin Infect Dis. 2021 07 01; 73(1):e28-e38.
-
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021 06; 3(6):e360-e370.
-
Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review. EBioMedicine. 2021 Mar; 65:103274.
-
Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016. Clin Infect Dis. 2019 09 05; 69(Suppl 2):S49-S57.